WeVote
Log In

Bill

Bill

A 2699

Relates to the sale of kratom

2025 Regular Session Introduced by Scott Bendett and 6 co-sponsors

New York Assembly Bill A 2699 would regulate kratom sales (licensing, age limits, labeling) to protect consumers; currently held for consideration in Health.

HELD FOR CONSIDERATION IN HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 2699

Summary: Assembly Bill A 2699 — Relates to the sale of kratom

Overview

  • Jurisdiction: New York Assembly (bill number A 2699)
  • Title: Relates to the sale of kratom
  • Purpose: The caption indicates the bill would address the sale of kratom, likely through regulatory or consumer-protection measures. The specific provisions are not included in the provided materials.
  • Status: Held for consideration in Health
  • Introduced: January 22, 2025

Legislative History (timeline)

  • 2025-01-22: Referred to Health
  • 2025-05-19: Held for consideration in Health
  • 2025-05-19: Held for consideration in Health (duplicate entry in actions) Notes: The bill has progressed to the Health Committee and is currently not moving forward to passage, pending further action.

Sponsors

  • Primary sponsor: Scott H. Bendett
  • Cosponsors: Nader Sayegh, Robert Smullen, Joe DeStefano, Karl Brabenec, David McDonough, Keith Brown

Related Bills

  • S 8401 (prior-session) — Senate counterpart
  • S 3426 (companion) — Senate companion (listed twice, indicating separate or repeated references)

Potential Provisions (topic-oriented, not stated in provided text)

The provided information does not include the bill’s text or specific provisions. Based on the title and typical Kratom-related legislation, possible areas such bills often address include:
- Licensing or registration requirements for kratom retailers and distributors
- Age restrictions on purchases (e.g., prohibiting sales to minors)
- Packaging, labeling, and consumer disclosures
- Advertising restrictions or prohibitions on certain claims
- Retail location restrictions or enforcement mechanisms
- Penalties for violations and enforcement authority
- Definitions of kratom and related products to establish regulatory scope
- Safe-use or public health provisions and potential coordination with health or toxicology authorities

Note: The above items are not confirmed for A 2699 and should be verified against the bill’s actual text.

Who Would Be Affected

  • Kratom retailers, wholesalers, and online sellers operating in the state
  • Consumers who purchase or use kratom
  • State and local law enforcement and regulatory agencies
  • Public health and consumer protection agencies
  • Stakeholders in the kratom industry, including manufacturers and associations

Procedural and Timeline Considerations

  • The bill is currently in the Health Committee, with explicit action to hold for consideration, indicating it may undergo further review, possible amendments, or repositioning before any chamber vote.
  • If advanced, the bill would move to full chamber consideration and potentially to the Senate counterpart (S 8401 or S 3426) for concurrence.

Bottom Line

A 2699 is an Assembly bill focused on the sale of kratom, currently stalled in the Health Committee after initial referrals. The exact regulatory approach remains unknown from the provided materials, but the bill is part of a broader legislative dialogue including a Senate companion and prior-session related measures.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.